Generalized Myasthenia Gravis
1 competing product in clinical development for Generalized Myasthenia Gravis.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Satralizumab | Chugai Pharmaceutical | Phase 3 | Terminated | 32 |
1 competing product in clinical development for Generalized Myasthenia Gravis.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Satralizumab | Chugai Pharmaceutical | Phase 3 | Terminated | 32 |